ヘルスケア研究受託機関市場：タイプ別、サービス別-2023～2030年の世界予測

ヘルスケア研究受託機関の世界市場は、2023年に568億6,000万米ドル、CAGR 11.80%で大幅な成長が予測され、2030年には1,243億米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のヘルスケア研究受託機関市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ヘルスケア研究受託機関の世界市場規模および予測は？

2.予測期間中、世界のヘルスケア研究受託機関市場を形成するCOVID-19の阻害要因と影響は？

3.ヘルスケア研究受託機関の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.ヘルスケア研究受託機関の世界市場における競争戦略は？

5.ヘルスケア研究受託機関の世界市場における技術動向と規制の枠組みは？

6.ヘルスケア研究受託機関の世界市場における主要ベンダーの市場シェアは？

7.ヘルスケア研究受託機関の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬会社によるエンドツーエンドサービスのアウトソーシングの傾向が拡大
    • 再生医療への投資の拡大
    • 専門的な検査サービスのニーズが高まる
  • 抑制要因
    • 熟練した専門家の減少
  • 機会
    • バイオシミラーおよび生物製剤分野からの新たな需要
    • ヘルスケア受託研究機関による新技術の導入
  • 課題
    • ヘルスケア研究受託機関サービスの品質問題
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ヘルスケア研究受託機関市場：タイプ別

• イントロダクション
• 臨床
  • 第I相試験サービス
  • 第II相試験サービス
  • 第III相試験サービス
  • 第IV相試験サービス
• 創薬
  • 候補特定
  • 候補最適化
  • 対象検証
• 前臨床

第7章 ヘルスケア研究受託機関市場：サービス別

• イントロダクション
• 生物学的統計
• 臨床モニタリング
• データ管理
• 研究員への支払い
• ラボ
• メディカルライティング
• 患者および施設の募集
• プロジェクト管理/臨床供給管理
• 品質管理・保証
• 規制・医療関係
• 技術

第8章 南北アメリカのヘルスケア研究受託機関市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のヘルスケア研究受託機関市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのヘルスケア研究受託機関市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
• FIGURE 2. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2022 VS 2030
• FIGURE 3. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
• FIGURE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET DYNAMICS
• FIGURE 8. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 12. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 18. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT & SITE RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 44. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 66. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 67. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 70. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 71. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 139. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 140. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 155. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 156. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 159. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 160. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 197. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 198. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 199. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET LICENSE & PRICING

The Global Healthcare Contract Research Organization Market is forecasted to grow significantly, with a projected USD 56.86 billion in 2023 at a CAGR of 11.80% and expected to reach a staggering USD 124.30 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Healthcare Contract Research Organization Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Healthcare Contract Research Organization Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead Identification, Lead Optimization, and Target Validation. The Pre-Clinical is projected to witness significant market share during forecast period.

Based on Service, market is studied across Bio-Statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient & Site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology. The Laboratory is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Healthcare Contract Research Organization Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Healthcare Contract Research Organization Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Contract Research Organization Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Contract Research Organization Market?

4. What is the competitive strategic window for opportunities in the Global Healthcare Contract Research Organization Market?

5. What are the technology trends and regulatory frameworks in the Global Healthcare Contract Research Organization Market?

6. What is the market share of the leading vendors in the Global Healthcare Contract Research Organization Market?

7. What modes and strategic moves are considered suitable for entering the Global Healthcare Contract Research Organization Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Healthcare Contract Research Organization Market, by Type, 2022 vs 2030
• 4.3. Healthcare Contract Research Organization Market, by Service, 2022 vs 2030
• 4.4. Healthcare Contract Research Organization Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • 5.1.1.2. Growing investments in regenerative medicine
    • 5.1.1.3. Increasing need among specialized testing services
  • 5.1.2. Restraints
    • 5.1.2.1. Reduced skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging demand from biosimilars and biologics sector
    • 5.1.3.2. Incorporation of novel technologies by healthcare contract research organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Quality issues of healthcare CRO services
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Healthcare Contract Research Organization Market, by Type

• 6.1. Introduction
• 6.2. Clinical
  • 6.2.1. Phase I Trial Services
  • 6.2.2. Phase II Trial Services
  • 6.2.3. Phase III Trial Services
  • 6.2.4. Phase IV Trial Services
• 6.3. Drug Discovery
  • 6.3.1. Lead Identification
  • 6.3.2. Lead Optimization
  • 6.3.3. Target Validation
• 6.4. Pre-Clinical

7. Healthcare Contract Research Organization Market, by Service

• 7.1. Introduction
• 7.2. Bio-Statistics
• 7.3. Clinical Monitoring
• 7.4. Data Management
• 7.5. Investigator Payments
• 7.6. Laboratory
• 7.7. Medical Writing
• 7.8. Patient & Site Recruitment
• 7.9. Project Management/Clinical Supply Management
• 7.10. Quality Management/ Assurance
• 7.11. Regulatory/Medical Affairs
• 7.12. Technology

8. Americas Healthcare Contract Research Organization Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Healthcare Contract Research Organization Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Research Organization Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing